EGOI-PCOS
  • The Group
    • Experts on Inositol
    • Experts on PCOS
    • Mission
    • Regulations and Statute
  • Clinical Centers
  • Publications
  • Activities
    • Fellowship
  • Affiliations
    • Support
  • Register
  • Login
Select Page

Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model.

Oct 14, 2018

Authors: Bevilacqua A, Dragotto J, Giuliani A, Bizzarri M

The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review

Jan 8, 2018

Authors: Antoaneta Gateva, Vittorio Unfer and Zdravko Kamenov

Can High Levels of D-chiro-inositol in Follicular Fluid Exert Detrimental Effects on Blastocyst Quality?

Dec 2, 2017

Authors: K. Ravanos, G. Monastra, T. Pavlidou, M. Goudakou, N. Prapas

Combining treatment with myo-inositol and D -chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients

Nov 29, 2016

Authors: Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator During Weight Loss in Obese Women With and Without Polycystic Ovary Syndrome

Sep 18, 2016

Authors: Kai I Cheang, Sakita N Sistrun, Kelley S Morel, John E Nestler
« Older Entries
Next Entries »


Viale di Villa Massimo 37, 00161, Rome (Italy)
Email: office@egoipcos.com or info@egoipcos.com
P.IVA / VAT ID: 96501700585

Subscribe to our Newsletter

Terms of use

Privacy and Cookie Policy
Registration Privacy Policy

All Rights Reserved ©2020 The Experts Group on Inositols in Basic and Clinical Research (EGOI)